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Abstract
Background: Leishmaniasis remains among the most important parasitic diseases in the developing world and
visceral leishmaniasis (VL) is the most fatal. The hamster Mesocricetus auratus is a susceptible model for the
characterization of the disease, since infection of hamsters with L. infantum reproduces the clinical and
pathological features of human VL. In this context, it provides a unique opportunity to study VL in its active
form. The main goal of this study was to evaluate the clinical, biochemical, and hematological changes in male
hamsters infected through different routes and strains of L. infantum.
Methods: In the current study, hamsters (Mesocricetus auratus) were infected with the L. infantum strains
(WHO/MHOM/BR/74/PP75 and MCAN/BR/2008/OP46) by intradermal, intraperitoneal and intracardiac routes.
The animals were monitored for a nine month follow-up period.
Results: The hamsters showed clinical signs similar to those observed in classical canine and human symptomatic VL,
including splenomegaly, severe weight loss, anemia, and leucopenia. Therefore the OP46 strain was more infective,
clinical signs were more frequent and more exacerbated in IC group with 80 to 100 % of the animals showing
splenomegaly, in the last month infection. Additionally, desquamation, hair loss and external mucocutaneous lesions
and ulcers localized in the snout, accompanied by swelling of the paws in all animals, were observed.
Consequently, the animals presented severe weight loss/cachexia, hunched posture, an inability to eat or
drink, and non-responsiveness to external stimuli. Furthermore, regardless of strain, route of inoculum and time
assessed, the animals showed renal and hepatic alterations, with increased serum levels of urea and creatinine
as well as elevated serum levels of aspartate aminotransferase and alanine aminotransferase.
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Conclusions: These results strongly suggest that the inoculation through the intracardiac route resulted in a
higher severity among infections, especially in the sixth and ninth month after infection via intracardiac,
exhibited clinical manifestations and biochemical/hematological findings similar to human visceral leishmaniasis.
Therefore, we suggest that this route must be preferentially used in experimental infections for pathogenesis studies
of VL in the hamster model.
Keywords: Hamster, Mesocricetus auratus, Leishmania infantum, Experimental infection, Hematological and biochemical
alterations
Background
Human visceral leishmaniasis (HVL) is a severe disease,
with a high degree of mortality if not diagnosed and
treated appropriately. Visceral leishmaniasis (VL) has an
estimated incidence of 500,000 new cases arising each
year worldwide and can be accompanied by the appear-
ance of various typical clinical signs such as chronic
fever, hepatosplenomegaly, weight loss/cachexia, pro-
gressive anemia, pancytopenia and hypergammaglobuli-
nemia [1–3]. The typical outcome of symptomatic
clinical VL is critically influenced by the host’s immune
response, and systemic infection is characterized by the
spread of the parasites mainly to the spleen, liver, lymph
nodes and bone marrow [4–8]. Progress in developing
new prophylactic and therapeutic strategies depends on
animal models that can reproduce the course of the hu-
man disease to allow an understanding of the infection
and its evolution [7, 9]. Nonetheless, in animals suscep-
tible to infection by Leishmania, the outcome of experi-
mental infection depends not only on host immunity but
also on a combination of factors, such as inoculated spe-
cies, strain virulence, nature of the inoculum, number of
parasites and route of inoculation [7, 10].
Different species of experimental animals, such as mice
and hamsters, have been used for studying HVL [5–7].
Mice are genetically resistant or susceptible to infection
but even susceptible mice can contain the infection and
prevent overt disease [11]. Initially, parasite growth is
observed in the liver and spleen, but within 4–5 weeks
of the infection, the liver parasitism is resolved by a
Th1-dependent granulomatous response [4, 12, 13].
Thereafter, the parasite persists as a chronic infection in
the spleen, with gradual destruction of the organ architec-
ture [5, 14–16]. Several other experimental animal models
of VL have been developed through the years [7, 17–23].
Of these, the hamster (Mesocricetus auratus) represents a
good model for VL as it has a unique susceptibility to a
variety of intracellular pathogens [14, 23]. Moreover,
it develops the majority of immunopathological alter-
ations characteristic of the human disease, with growth
of parasites in the bone marrow, spleen and liver; clin-
ical and hematological symptoms such as hepatosple-
nomegaly, depressed lymphocyte proliferation, anemia,
leucopenia and glomerulonephritis; death by 9–10
weeks after visceral infection [7, 14]. This model has
been extensively used for studies on disease pathogen-
esis and immunosuppression [14, 24–26] and to test ef-
ficacy of drugs and vaccines [26–32].
The susceptibility of hamsters to infection by Leish-
mania spp. depends on a number of host factors (e.g.
age and sex) that plays an important role in modulating
the immune system [33, 34]. Male hamsters infected at a
juvenile stage have been shown to be more susceptible
to infection and to have higher and more severe lesions
and greater parasite burden in lymph nodes compared
with females [35]. After challenge, male hamsters
showed decreased weight gain and higher mortality rates
at any given time point than female or control male ham-
sters. Body weight has been shown to be a relevant de-
terminant of the clinical outcome of the infection in
hamsters with VL [36].
In a paper published recently [7], we noticed that the
route of infection and the type of strain influence the
humoral response and parasite load in the liver and
spleen of hamsters experimentally infected with L. infan-
tum. In addition, we have shown the importance of
PCR to determine the parasitism in a hamster model,
given intense use of this model in the last decade to test
VL drugs and vaccines [7]. However, it is not clear, how
the parasite alters the clinical and laboratory parameters
in hamsters experimentally infected with L. infantum
and how these alterations contribute to the pathology
associated with VL. In this study the main goal was to
investigate the clinical and laboratory changes of the ani-
mals inoculated with L. infantum strains (MHOM/BR/
74/PP75 and MCAN/BR/2008/OP46) by (intradermal
[ID], intraperitoneal [IP], and intracardiac [IC]) routes.
Methods
Ethical approval
This study was reviewed and approved by the Institu-
tional Animal Ethics Committee (approval ID number
2009/09). The experimental procedures were carried
out in strict accordance with the recommendations of
the Brazilian regulations relating to experimental biol-
ogy and medicine.
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Animals
One-month-old male Syrian golden hamsters (Mesocri-
cetus auratus) were obtained from the Central Animal
Facility at the Universidade Federal de Ouro Preto
(CCA/UFOP). The animals were housed in appropriate
plastic cages and fed with standard rodent food pellet
and water ad libitum.
Leishmania parasites and experimental infection
The L. infantum strains MHOM/BR/74/PP75 and MCAN/
BR/2008/OP46 were used in experimental infection of
hamsters. The MCAN/BR/2008/OP46 strain was isolated
from a symptomatic naturally infected dog provided by the
Center of Zoonosis Control (CCZ), Governador Valadares,
Brazil. The parasite growth, inoculums and infection were
carried out as previously described by Moreira et al.[7].
Experimental groups, follow-up, and collection of samples
Two groups of 120 hamsters each were infected with L.
infantum (WHO/MHOM/BR/74/PP75 and MCAN/BR/
2008/OP46) strains, respectively. Hamsters were inocu-
lated with 1 × 107 promastigotes of L. infantum in the
stationary growth phase by intradermal, (n = 40), intra-
peritoneal (n = 40), and intracardiac (n = 40), routes.
Eighty uninfected hamsters were used as a control group
(C, n = 80). The animals were monitored for a
nine month follow-up period. The promastigotes of L.
infantum were concentrated in a final volume that
depended on the inoculation route to be used. For the
ID route, 20 μL of inoculum was injected into the right
ear of each animal, while 500 μL was used for IP inocu-
lation. IC inoculation required a final volume of 200 μL
in animals that were anesthetized with 2.5 % sodium
pentobarbital at a dose of 10 mg/kg intraperitoneally.
Blood samples were collected by cardiac punction
from each of the 10 hamsters per group at 1, 3, 6 and
9 months after inoculation. One blood sample from each
animal was centrifuged to obtain serum for biochemical
examinations, and a second sample was collected and
transferred to a tube containing EDTA (Sigma Chemical
Co) as the anticoagulant for measurement of
hematological parameters. The hamsters were subse-
quently euthanized, and the liver and spleen were col-
lected aseptically and weighed, and lesions were
analyzed based on color, size, shape, surface appearance
and consistency.
Clinical evaluation
The hamsters were monitored for appearance, activity,
swelling, pain, desquamation, hair loss and ulceration.
Animals were weighed using a calibrated balance (ana-
lytical balance FA-2104 N Bioprecisa) before L. infantum
infection and on the day of euthanasia (1, 3, 6 and
9 months after inoculation). The critical point for this
study was reached at nine months after infection when
hamsters exhibited any of the following criteria: severe
weight loss, inability to eat or drink, or non responsive-
ness to external stimuli.
Blood sample collection for hematological and
biochemical analysis
Blood was collected by cardiac puncture after adminis-
tration of anesthetic (sodium thiopental 2.5 % at dose of
10 mg/kg intraperitoneally) and transferred to tubes
containing EDTA (Sigma Chemical Co) as the anti-
coagulant. The absolute counts for leukocytes, erythro-
cytes, hematocrit, hemoglobin, and platelets in each
sample was obtained using an auto Hematology
Analyzer (Mindray BC-2800Vet, Hamburg, Germany).
The leukocyte count was determined by the number of
leukocytes per cubic millimeter. The differential cell
count was performed in the blood smears stained by
Giemsa and cell counts were performed by a blood cell
counter to determine the absolute number of cells, using
an optical microscopy.
Blood for biochemical analysis was collected in glass
tubes without anticoagulant and then centrifuged to col-
lect the serum. The biochemical evaluations consisted of
the following tests: determination of urea and creatinine
to gauge renal function and the measurement of alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) as liver function tests. For these analyses, Auto-
matic Biochemical (CELM SBA-200, Barueri, SP, and
Brazil) and Commercial Labtest kits (Labtest Diagnostica
SA, Lagoa Santa, MG, and Brazil) were employed follow-
ing the methods described by the manufacturers.
Parasite load
The parasite load was detected by quantitative real-time
PCR methods as described elsewhere by Moreira et al.
[7]. Briefly, total genomic DNA was extracted from ap-
proximately 20 mg of tissue (spleen and liver). For
spleen samples, extraction with Wizard TM Genomic
DNA Purification Kit (Promega H, Madison, WI, USA)
was used following manufacturer’s recommendations.
To obtain the DNA of the liver samples the CTAB
method was used as previously described by Moreira et al.
[7]. The concentration of DNA obtained from tissues was
determined with a spectrophotometer (NanoVue Plus, GE
Healthcare Products, Piscataway, NJ, USA). In order to
quantify parasite burdens, we used the following primers:
forward: 5′ TGT CGC TTG CAG ACC AGA TG 3′, and
reverse: 5′GCA TCG CAG GTG TGA GCA C 3′ that
amplified a 90-bp fragment of a single-copy of the DNA
polymerase gene of L. infantum (GenBank accession num-
ber AF009147). PCR was carried out in a final volume of
25 μL containing 200 nM forward and reverse primers, 1×
SYBER GREEN reaction master mix (Applied Biosystems,
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USA), and 5 μL of template DNA. Standard curves were
prepared for each run using known quantities of pGEM®-T
plasmids (Promega, USA) containing inserts of interest.
The results were expressed as the number of amastigotes in
20 ng of DNA of tissue (spleen and liver).
Statistical analysis
All analyses were conducted using Prism 5.0 software
package (Prism Software, Irvine, CA, USA). Normality
of the data was established using the Kolmogorov-
Smirnoff test. Differences between experimental groups
were performed using one-way ANOVA followed by
Tukey’s test. Spearman’s rank correlation was also per-
formed to investigate associations between parasite load
and relative weight of organs. Differences with P < 0.05
were considered significant.
Results
The clinical pathological signs and evolution of hamster
mimics the classic canine and human symptomatic VL
To evaluate the progression of infection, clinical signs
were analyzed at 1, 3, 6 and 9 months after inoculation
with PP75 and OP46 L. infantum strains via three dif-
ferent routes (ID, IP and IC). Clinical signs suggestive
of VL were observed in all groups and were generally
more evident at 6 and 9 months after experimental in-
fection for both strains. Animals inoculated with the
PP75 strain via the IP route showed clinical signs earl-
ier; however, the symptoms disappeared by the ninth
month of monitoring. The animals infected with PP75
strain via the ID and IC routes showed clinical signs
after 6 months, which were more severe at 9 months in
hamsters inoculated via the IC route. Hamsters infected
with the OP46 strain showed clinical signs suggestive
of VL (splenomegaly and ascites) from 3 months after
infection regardless of route. Overall, the OP46 strain
was associated with more severe clinical signs than
PP75 during the monitoring period for all three routes
(Table 1). Interestingly, 9 months after IC infection
with the OP46 strain, we found desquamation, hair
loss, and external mucocutaneous lesions and ulcers lo-
calized in the snout, accompanied by edema of the
paws in all animals. Furthermore, the animals exhibited
severe weight loss, hunched posture, an inability to eat
or drink and non-responsiveness to external stimuli
(Fig. 1).
An increase in the relative weight of the liver was ob-
served at 9 months in animals infected with the PP75
strain via the IC route compared to the other groups.
This increase was also observed in the IC group of ani-
mals infected with the OP46 strain beginning in the
sixth month and persisting at 9 months (Fig. 2a). Macro-
scopically, the livers of animals infected with both strains
and by the IC route appeared friable; changed color from
red to pale yellowish brown (Fig. 2b). In hamsters in-
fected with the PP75 strain, the correlation analysis re-
vealed that relative liver weight was negatively correlated
with the parasite load in the IP group, but positively cor-
related in the IC group. In animals inoculated with the
OP46 strain, the correlation analysis revealed that rela-
tive liver weight was positively correlated with its para-
site load in both the IP and IC groups (Fig. 2c).
Table 1 Clinicopathological analysis of hamsters experimentally infected with L. infantum. Absolute (n) and percentage (%)
Time/infection
(months)
Clinical signs Experimental groups, n (%)
MHOM/BR/74/PP75 strain MCAN/BR/2008/OP46 strain
ID IP IC ID IP IC
1 – – – – – – –
3 Splenomegaly – 1/10 (10) – – 1/10 (10) 8/10 (80)
Ascites – 1/10 (10) – 6/10 (60) 1/10 (10) –
6 Splenomegaly – – 2/10 (20) 1/10 (10) 7/10 (70) 10/10 (100)
Hepatomegaly 1/10 (10) – – – – 1/10 (10)
Ascites 4/10 (40) 4/10 (40) 3/10 (30) 4/10 (40) 1/10 (10) 6/10 (60)
Emaciationa – – – 1/10 (10) – 9/10 (90)
9 Splenomegaly 1/10 (10) – 7/9 (77) 1/10 (10) 7/8 (87) 6/6 (100)
Hepatomegaly – – 3/9 (33) 1/10 (10) – 1/6 (16)
Ascites 1/10 (10) – 1/9 (11) – 3/8 (37) 6/6 (100)
Emaciationb – – 2/9 (22) – – 6/6 (100)
Skin lesion – – – – – 6/6 (100)
Swelling of the paw – – – – – 6/6 (100)
Animals were infected with PP75 and OP46 strains of L. infantum by different routes of inoculation: intradermal (ID), intraperitoneal (IP), and intracardiac (IC)
aWeight loss with preservation of the general condition of the animal
bAccentuated/cachexia weight loss (observed only in the group inoculated by the IC route)
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In the analyses of the spleen, hamsters infected with
the PP75 strain and inoculated by the IP route had a
slight increase in the splenic relative weight compared
with the other groups (C, ID and IC) at 3 months. A
greater increase in the splenic relative weight was ob-
served at 9 months after infection by the IC route com-
pared to the C, ID, and IP groups. Animals infected with
the OP46 strain via the IP route showed an increase in
the relative weight of spleen at 1 month compared to
the C group and at 6 months compared to the C and ID
groups. The IC route demonstrated a gradual increase in
the relative weight of the spleen during the course of in-
fection. This increase was observed with regard to the C,
ID, and IP groups at 3, 6, and 9 months, and also in rela-
tion to the C and ID groups at 1 month (Fig. 3a). The
macroscopic splenic changes most frequently observed
included an increase in the volume of the organ (spleno-
megaly), thickening of edges, rugose and an irregular
surface and dark coloration, suggesting hyperemia. It is
noteworthy that these alterations were more intense in
animals infected with the OP46 strain (Fig. 3b). Further-
more, the correlation analysis revealed that splenic rela-
tive weight was positively correlated with the parasite
load in the IP and IC groups for both strains (Fig. 3c).
Hamsters infected with the OP46 strain through the
intracardiac route exhibit severe anemia with a reduction
of red blood cells, hemoglobin, and hematocrit
In hamsters infected with the PP75 strain, a reduction in
the hematocrit was observed in all groups (ID, IP, and
IC) after 1 month of infection. At 3 months after infec-
tion, an increase in the number of platelets was observed
in the IP and IC groups compared to the control ani-
mals. Reduced counts for erythrocytes, hemoglobin and
hematocrit were observed at 6 months. The only differ-
ence at 9 months, however, was an increase in the num-
ber of erythrocytes in the IP group compared to the C
and ID groups.
In animals infected with the OP46 strain, severe
anemia was observed in the IC group from the sixth
month of infection, with a reduction of red blood cells,
hemoglobin and hematocrit in comparison with the
other groups (Table 2).
With regard to the white blood cells, data analysis re-
vealed statistical differences in the animals infected with the
PP75 strain at 3 months, with a reduction in the number of
eosinophils in animals inoculated by the IP route in relation
to the C group. Moreover, at 9 months a significant de-
crease in the monocyte population was observed in the IC
group compared with the control group. In contrast, after
1 month of infection with the OP46 strain by the ID and IP
routes, there was an increased number of monocytes in re-
lation to the C group. After 3 months of infection an in-
crease in the lymphocyte population was observed in the
group inoculated via the IP route compared to group C. At
this same time, animals infected via the IC route presented
with leucopenia compared to the C, ID, and IP groups,
which was characterized by a remarkable reduction in the
monocyte population compared to the C group. After
6 months of infection, the IC group showed some alter-
ations: a reduction in the total number of neutrophils was
observed compared to the ID group; the number of eosino-
phils in relation to the C and ID groups was diminished;
the number of lymphocytes was reduced in relation to the
C, ID, and IP groups; and the number of monocytes de-
clined in relation to the C and IP groups. In a similar man-
ner, at 9 months after infection with the OP46 strain,
hamsters inoculated by the IP and IC routes were more
likely to have leucopenia compared to the C and ID groups,
which was characterized by a decrease in the total neutro-
phils, eosinophils, and monocytes (data not shown).
Hamsters demonstrated consistent biochemical changes
which present themselves as strong clinical markers of
visceral leishmaniasis
The biochemical evaluations are shown in Fig. 4 and
consist of the following tests: liver function tests,
A B C
Fig. 1 Macroscopic changes observed in hamsters 9 months after infection with the OP46 strain. In a normal hamster, b-c severe cachexia, hair
loss, swelling in the paws and mucocutaneous lesions (snout)


























































































Fig. 2 Relative weight of the liver of uninfected hamsters as a control group (C, n = 10 animals/time; white) and hamsters experimentally infected
with L. infantum (PP75 or OP46 strain) by routes of inoculation: intradermal (ID, n = 10 animals/time; light gray), intraperitoneal (IP, n = 10 animals/
time; dark gray), or intracardiac (IC, n = 10 animals/time; black) after 1, 3, 6, and 9 months of infection. The results are expressed as mean ±
standard deviation. Significant differences (P < 0.05) between infection with the different routes of inoculation are represented by the connected
lines (a). Macroscopic changes in the liver of uninfected hamsters as a control group (C; white) and in hamsters experimentally infected with L.
infantum (PP75 or OP46) by the IC route of inoculation at 9 months of infection. The liver of control hamsters with a normal appearance; liver of
hamsters infected with strains PP75 and OP46 appeared friable; changed color from red to pale yellowish brown (b). Correlation between parasite
load and relative weight of the liver in hamsters experimentally infected with L. infantum (PP75 or OP46 strain) by routes of inoculation:
intraperitoneal (IP; dark gray) or intracardiac (IC; black) after 1, 3, 6 and 9 months of infection. Spearman’s correlation index r and P-values are
shown on the graphs; the connecting lines illustrate positive and negative correlation indices (c)
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including the measurement of AST and ALT, and renal
function tests based on urea and creatinine levels.
In animals infected with the PP75 strain, an increase
in the serum AST level was observed in the IC group in
relation to the C and ID groups at 1 month as well as at
9 months in comparison to all other groups (C, ID, and
IP). Furthermore, an increase in the serum ALT level
was observed in the IC group at 1 month compared to
the C group and at 9 months in relation to all other
groups (C, ID, and IP) (Fig. 4).
In hamsters infected with the OP46 strain, an increase
in the serum AST level was observed in the IC group
compared to all groups at 3 months, and in relation to
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Fig. 3 Relative weight of the spleen in uninfected hamsters as a control group (C, n = 10 animals/time; white) and hamsters experimentally infected
with L. infantum (PP75 or OP46 strain) by routes of inoculation: intradermal (ID, n = 10 animals/time; light gray), intraperitoneal (IP, n = 10 animals/time;
dark gray), or intracardiac (IC, n = 10 animals/time; black) after 1, 3, 6 and 9 months of infection. The results are expressed as mean ± standard deviation.
Significant differences (P < 0.05) between infection with the different routes of inoculation are represented by the connected lines (a). Macroscopic
changes in the spleen of uninfected hamsters as a control group (C) and in hamsters experimentally infected with L. infantum (PP75 or OP46 strain) by
the IC route of inoculation at 9 months of infection. The macroscopic splenic changes included increase in the volume of the organ (splenomegaly),
thickening of edges, rugose and irregular surface and dark coloration (b). Correlation between parasite load and relative weight in the spleen of
hamsters experimentally infected with L. infantum (PP75 or OP46 strain) by different routes of inoculation: intraperitoneal (IP; dark gray) or intracardiac
(IC; black) after 1, 3, 6 and 9 months of infection. Spearman’s correlation index r and P-values are shown on the graphs; the connecting lines illustrate
positive and negative correlation indices (c)
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Similarly, the IP group showed an increase in the AST
level in relation to all groups at 3 months after infection
and at 9 months in relation to the C and ID groups.
Serum ALT levels were observed to be increased in the
IC group compared to all groups at 3 months. Further-
more, an increase of ALT was observed in the ID, IP,
and IC groups compared with the control group at
6 months of follow-up (Fig. 4).
Regarding renal function, increased levels of urea were
observed in the IC group compared to the C and IP
groups at 6 months after infection with the PP75 strain.
Moreover, after 9 months of infection, increased levels
of urea were observed in the three experimental groups
(ID, IP, and IC) compared to C group. Also, at the last
follow up, an increased serum level of urea in the IP and
IC groups in relation to the ID group was detected. In
the animals infected with the OP46 strain, increased
levels of urea were observed in the IC group compared
to all other groups (C, ID, and IP) at 3 and 9 months
(Fig. 4). The animals infected with the PP75 strain
presented increased serum creatinine levels in all in-
fected groups (ID, IP, and IC) compared to the control
group at 9 months (Fig. 4). Furthermore, animals in-
fected with the OP46 strain also presented an increased
serum creatinine level in the IC group compared to the
others (C, ID and IP) at 3 and 9 months after infection
(Fig. 4).
Discussion
In this study we investigated the clinical and laboratory
changes in male golden hamsters infected with L. infan-
tum in order to improve our understanding of the
pathogenesis studies and clinical aspects of VL. Previous
studies by Moreira et al. [7] demonstrated progressive
disease in hamsters infected with L. infantum, which
was closely related to the presence of high parasitism in
the spleen and liver. Herein we evaluated the clinical
signs and changes in hematological and biochemical pa-
rameters in hamsters that were experimentally infected
by routes (ID, IP, and IC) with strains of L. infantum




1 3 6 9 1 3 6 9
C group
Erythrocytes (106/mm3) 7.2 ± 0.3 7.2 ± 1.1 8.5 ± 1.2 8.4 ± 1.0 7.4 ± 0.4 7.0 ± 0.3 7.1 ± 0.2 6.7 ± 0.3
Hemoglobin (g/dL) 13.9 ± 0.6 13.5 ± 0.8 17.6 ± 2.1 17.5 ± 2.3 15.0 ± 1.0 13.3 ± 0.9 13.3 ± 0.5 13.2 ± 0.7
Hematocrit (%) 35.5 ± 3.6 34.6 ± 7.2 39.5 ± 5.5 38.4 ± 6.7 32.6 ± 1.5 30.5 ± 2.3 32.5 ± 2.3 33.2 ± 2.0
Platelets (106/mm3) 165.8 ± 37.4 142.6 ± 33.8 154.9 ± 143 127.4 ± 12.5 139.9 ± 20.8 136.4 ± 16.9 164.7 ± 15.5 174.0 ± 20.5
Strain/months after infection
PP75 strain OP46 strain
1 3 6 9 1 3 6 9
ID group
Erythrocytes (106/mm3) 6.5 ± 0.4 7.2 ± 0.2 6.5 ± 0.4a 8.5 ± 0.7 7.4 ± 0.3 6.8 ± 0.3 6.7 ± 0.8 6.9 ± 0.3
Hemoglobin (g/dL) 13.7 ± 1.1 13.6 ± 0.5 12.7 ± 1.0a 19.7 ± 4.5 15.2 ± 0.6 13.3 ± 0.7 12.6 ± 1.6 13.7 ± 0.3
Hematocrit (%) 29.3 ± 2.1a 36.3 ± 3.0 31.1 ± 2.7a 38.3 ± 3.9 33.9 ± 1.5 31.2 ± 3.0 33.6 ± 3.6 34.0 ± 2.0
Platelets (106/mm3) 123.8 ± 16.2 168.70 ± 25.26 138.3 ± 19.2 108.1 ± 18.0 156.8 ± 27.5 141.1 ± 24.4 185.5 ± 24.4 189.4 ± 27.3
IP group
Erythrocytes (106/mm3) 6.1 ± 0.1 6.8 ± 0.7 6.7 ± 0.2a 9.8 ± 0.5a,b 7.5 ± 1.0 7.1 ± 0.4 7.0 ± 0.5 6.2 ± 1.0
Hemoglobin (g/dL) 13.4 ± 0.5 13.1 ± 1.2 13.4 ± 0.4a 21.2 ± 1.3 14.4 ± 0.6 13.6 ± 1.2 12.8 ± 1.1 12.0 ± 2.0
Hematocrit (%) 28.9 ± 1.5a 38.7 ± 3.2 31.2 ± 2.7a 43.9 ± 2.2 32.0 ± 2.6 31.4 ± 3.2 36.1 ± 2.6 31.0 ± 4.2
Platelets (106/mm3) 134.1 ± 45.3 221.6 ± 75.0a 132.2 ± 23.4 126.3 ± 14.5 169.3 ± 35.4 145.6 ± 32.1 184.4 ± 32.7 174.6 ± 87.4
IC group
Erythrocytes (106/mm3) 6.6 ± 0.4 7.2 ± 0.7 6.8 ± 0.3a 9.2 ± 1.0 7.1 ± 0.4 6.7 ± 0.3 4.3 ± 1.4a,b,c 4.7 ± 1.9a,b, c
Hemoglobin (g/dL) 13.7 ± 0.8 13.8 ± 1.2 13.6 ± 0.7a 20.0 ± 2.4 14.5 ± 0.9 12.3 ± 1.6 7.0 ± 1.8a,b,c 10.1 ± 4.2a,b
Hematocrit (%) 30.1 ± 1.8a 35.0 ± 3.6 31.5 ± 2.4a 41.5 ± 4.3 31.6 ± 2.1 29.0 ± 4.4 21.0 ± 6.9a,b,c 25.0 ± 9.4a,b
Platelets (106/mm3) 134.1 ± 21.5 144.6 ± 22.3c 135.4 ± 13.5 108.5 ± 17.5 156.5 ± 17.0 110.9 ± 29.8 329.4 ± 153.5a,b,c 291.3 ± 136.4a,b,c
Values (mean ± standard deviation) erytrogram of uninfected hamsters as a control group (C) and infected animals with strains PP75 and OP46 of L. infantum by
different routes of inoculation: intradermal (ID), intraperitoneal (IP), intracardiac (IC). Significant differences (P < 0.05) are represented by letters a, b, crelated to the
C, ID and IP groups respectively
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(MHOM/BR/74/PP75 and MCAN/BR/2008/OP46) that
exhibit distinct degrees of virulence and pathogenicity.
The clinical signs observed in our study have also
been reported by several other researchers [14, 23,
37–39]. Wilson et al. [40] documented that the clin-
ical symptoms of VL in hamsters only occurred
10 months after ID inoculation of L. donovani. How-
ever, other studies found that progressive VL was
achieved after intradermal infection with 105 para-
sites, which is the route closer to natural transmission
by sand fly bites [22]. The hamsters showed clinical
signs similar to those observed in symptomatic HVL,
including splenomegaly and severe weight loss. In
contrast, the frequency of clinical signs when the ID
route was used with both strains was relatively low
during our study. However, clinical signs were more
evident at 9 months after infection with the PP75
strain inoculated by the IC route, but with low fre-
quency. With the OP46 strain, the clinical signs were





















































































Fig. 4 Activity of AST and ALT; urea and creatinine in the blood plasma of uninfected hamsters as a control group (C, n = 10 animals/time; white)
and in hamsters experimentally infected with L. infantum (PP75 or OP46 strain) by routes of inoculation: intradermal (ID, n = 10 animals/time; light
gray), intraperitoneal (IP, n = 10 animals/time; dark gray), or intracardiac (IC, n = 10 animals/time; black) after 1, 3, 6 and 9 months of infection. The
results are expressed as mean ± standard deviation. Significant differences with P < 0.05 between infection with the routes of inoculation are
represented by the connected line
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In other words, our results demonstrated an increased
pathogenicity of this strain.
At 9 months after infection with the OP46 strain by
the IC route, an accentuated weight loss (cachexia) was
observed, as well as mucocutaneous lesions accompan-
ied by localized ulcers in the snout and edema in the
paws. We speculate that the cachexia may have arisen
due to parasites spreading to the liver and spleen [7] as
well as the secondary mucocutaneous lesions. Moreover,
these data emphasize the capacity of the IC route to
cause a severe injury in hamsters, including cutaneous
lesion and edema of the lower limbs. These data corrob-
orate those reported by Nieto et al. [23] in hamsters in-
fected with promastigotes of L. infantum by the IC
route. This result clearly demonstrates that classical clin-
ical signs observed and reported in human and canine
VL also occur in experimental model hamsters. There-
fore, we can infer that the route of the inoculum and the
strain used are vital conditions for generating progres-
sive VL in the hamster model.
The classical hepatomegaly was an uncommon finding
in hamsters infected with either strains used in the
present work. However, we reported an increased rela-
tive liver weight in both groups (PP75 and OP46 strain)
when infection occurred by the IC route, and the weight
was closely correlated with an increased parasite load.
Our results indicate hepatomegaly not from the in-
creased size of the liver, but with regard to the weight
loss. Hepatomegaly is not necessarily always observed
during the disease, which has also been documented by
other authors [41, 42]. These differences, as well as the
other changes, are probably inherent to the complexity
of the effects caused by the parasite and the host im-
mune response. Macroscopically, the liver of animals in-
oculated via the IC route appeared friable; containing
white foci distributed across the liver surface and chan-
ged color from red to pale yellowish brown. These same
macroscopic changes were also described by other au-
thors for hamsters experimentally infected with L. infan-
tum and L. donovani using the IC route for the
inoculums [42, 43]. At 9 months, the spleen size in ani-
mals inoculated via the IC route was exorbitant com-
pared to the control group for both strains. We
hypothesized that this splenomegaly was due to the high
parasitism displayed by these animals [7].
Knowledge of the biochemical and hematological param-
eters in hamsters experimentally infected with L. infantum
is extremely limited. Although hematological and biochem-
ical profiles have limited applications for a VL diagnosis,
they can be very important in evaluating the clinical prog-
nosis status, as well as in elucidating the pathogenesis to
define therapeutic approaches [8, 44–47]. Blood abnormal-
ities are frequently observed in both humans and animal
models for VL [48–50]. Leucopenia, neutropenia, and
eosiponenia are frequently found in HVL [51–53]. Accord-
ing to Reis et al. [44] the impaired hematological picture in
CVL is associated with severe clinical manifestations and
demonstrated by leucopenia, which is characterized by lym-
phopenia, eosinopenia and monocytopenia. Herein, the
changes in the hematological parameters of hamsters in-
fected with the PP75 strain were not expressive; we de-
tected monocytopenia in the last month of infection only in
the IC group. However, the hamsters infected with the
OP46 strain through the IC and IP routes presented intense
monocytopenia accompanied by leucopenia after the third
month of infection. The leucopenia observed in the IC and
IP groups at 6 and 9 months after experimental infection,
showed a typical LV immunosuppression marked by a de-
crease of neutrophils, eosinophils, lymphocytes and/or
monocytes. Thus, in the context of our study, the classical
hematological changes observed in human and canine VL
have been reproduced. The results also confirm that the
hematological changes in the IP and IC groups, accompan-
ied by the presence of clinical signs suggestive of active VL
(especially splenomegaly), are associated with high tissue
parasitism (spleen and liver) previously observed by Mor-
eira et al. [7]. These findings resulted from the complex
interaction related to the potential virulence and pathogen-
icity of each of the two strains used.
Normocytic normochromic anemia is a common find-
ing in patients with the chronic form of the human dis-
ease [52] and also for dogs with CVL [44]. In our study
the main changes in the red blood cells of hamsters in-
fected with the PP75 strain occurred at 1 and 6 months
after infection in the three experimental groups (ID, IP,
and IC). Moreover, in animals infected with the OP46
strain, these changes were observed from the sixth
month, and were restricted to the IC group only, in
which severe anemia, marked by the reduction of eryth-
rocytes, hematocrit and hemoglobin was observed.
Anemia was also demonstrated by Rica-Capela et al. [38]
in 70–80 % of hamsters experimentally infected with dif-
ferent forms (promastigotes and amastigotes) of L.
infantum.
Changes in the levels of serum aminotransferase en-
zymes (ALT and AST) are considered important indi-
cators of hepatocyte structural damage. Measuring
serum levels of ALT and AST allowed the presence of
changes in the permeability of these cells to be deter-
mined. Although a few studies have attempted to as-
sess alterations in the levels of AST and ALT in the
LV hamster model, several authors have reported in-
creased serum levels of these enzymes in HVL [47] as
well as in CVL [54–56]. Thus, we believe that labora-
tory monitoring of AST and ALT should be consid-
ered when using this model mainly for drug studies
for VL. Herein, the increased ALT and AST levels in
hamsters from the IP and IC groups at different time
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points were observed for both strains (PP75 and
OP46). Our results provide advanced understanding
of the role of these biomarkers in the hepatic func-
tion during ongoing experimental hamster infection.
Evaluation of renal function consisted of determining
serum levels of urea and creatinine. Our results revealed a
renal alteration characterized by an increase in urea and
creatinine in both strains by different routes of inoculation
and at different time points. The most common change in
renal physiology in VL is glomerulonephritis, while amyl-
oidosis is less common [57]. Studies conducted by Rica-
Capela et al. [38] showed a large amount of amyloid in the
liver and spleen of hamsters experimentally infected with
amastigotes and promastigotes of L. infantum. These data
suggest kidney injury in the animals, perhaps due to the de-
position of immune complexes in lymphoid organs.
Therefore, these findings represent an advance in the
knowledge of the involvement of experimental infection
in hamster model with L. infantum. Data indicate that
the infectivity capacity of the parasite, the inoculum
routes and the dose used as well as the biological form
of the parasite (amastigote and promastigote) can influ-
ence the course of the natural history of experimental
VL. These aspects make it difficult to select an ideal ex-
perimental model that is capable of reproducing the dis-
ease in its visceral form exhibiting various clinical
manifestations and evolving from acute to chronic form
[7, 14, 21]. However, here we showed that the route of
infection and the strain used was crucial to influence the
biochemical and hematological parameters evaluated in
this study. Thus the IC route proved to be more aggres-
sive than other routes used and OP46 more virulent and
a more pathogenic strain compared to the reference
PP75 strain.
Conclusion
Taken together, the results obtained from this experi-
mental infection of male golden hamsters infected with
L. infantum having distinct virulence and pathogenicity
profiles show that it is possible to reproduce a disease
with differing degrees of severity. Many alterations and
typical biomarkers, such as hematological/biochemical
factors and pathological and clinical signs frequently ob-
served in human and/or canine VL, were also detected
in this hamster model. Thus, the results presented in
this paper indicate that the golden hamster (M. auratus)
constitutes an excellent model for analysis of experimen-
tal infections caused by different strains of L. infantum
inoculated by different routes, reinforcing its use in
pathogenesis studies of VL.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ABR, RCG, JVS, CMC and NDM planned the study design. NDM performed
laboratory work. JMOC, MTR, BMR, PMAV, HGK and NDM have made
substantial contributions to analysis and interpretation of data. BMR, WCV
and NDM provided substantial improvement of the manuscript and RCG and
ABR provided scientific supervision of the study. All authors approved the
final version of the manuscript.
Acknowledgments
CMC, RCG, JV-S, BMR and ABR thank Conselho Nacional de Desenvolvimento
Científico e Tecnológico, Brazil, WCV and NDM by CAPES/PNPD for fellowships.
The authors are also grateful for Universidade Federal de Ouro Preto (UFOP), the
use of facilities at Centro de Ciência Animal (Universidade Federal de Ouro Preto).
We are also grateful for the specific grants (FAPEMIG, CNPq, and CAPES) from
these financial agencies.
Author details
1Laboratório de Imunopatologia, Núcleo de Pesquisas em Ciências
Biológicas/NUPEB, Universidade Federal de Ouro Preto, Ouro Preto, Minas
Gerais, Brasil. 2Laboratório de Pesquisas Clínicas, Departamento de Análises
Clínicas, Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto,
Minas Gerais, Brasil. 3Laboratório de Morfopatologia, Departamento de
Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas
Gerais, Brasil. 4Laboratório de Biologia das Interações Celulares,
Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo
Horizonte, Minas Gerais, Brasil.
Received: 23 December 2015 Accepted: 21 March 2016
References
1. Carvalho EM, Teixeira RS, Johnson Jr WD. Cell-mediated immunity in
American visceral leishmaniasis: reversible immunosuppression during acute
infection. Infect Immun. 1981;33(2):498–500.
2. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson Jr WD. Absence of
gamma interferon and interleukin 2 production during active visceral
leishmaniasis. J Clin Invest. 1985;76(6):2066–9.
3. van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M.
Combination therapy for visceral leishmaniasis. Lancet Infect Dis.
2010;10(3):184–94.
4. Wilson ME, Sandor M, Blum AM, Young BM, Metwali A, Elliott D, RG,
Weinstock JV. Local suppression of IFN-gamma in hepatic granulomas
correlates with tissue-specific replication of Leishmania chagasi. J Immunol.
1996;156(6):2231–9.
5. Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Destruction of follicular
dendritic cells during chronic visceral leishmaniasis. J Immunol.
1997;158(8):3813–21.
6. Tropia de Abreu R, Carvalho M, Carneiro CM, Giunchetti RC, Teixeira-
Carvalho A, Martins-Filho OA, Coura-Vital W, Correa-Oliveira R, Reis AB.
Influence of clinical status and parasite load on erythropoiesis and
leucopoiesis in dogs naturally infected with Leishmania (Leishmania)
chagasi. PLoS One. 2011;6(5):e18873.
7. Moreira N, Vitoriano-Souza J, Roatt BM, Vieira PM, Ker HG, de Oliveira
Cardoso JM, Giunchetti RC, Carneiro CM, de Lana M, Reis AB. Parasite
burden in hamsters infected with two different strains of Leishmania
(Leishmania) infantum: “Leishman Donovan units” versus real-time PCR.
PLoS One. 2012;7(10), e47907.
8. Nicolato Rde C, de Abreu RT, Roatt BM, Aguiar-Soares RD, Reis LE, Carvalho
M, Carneiro CM, Giunchetti RC, Bouillet LE, Lemos DS et al. Clinical forms of
canine visceral leishmaniasis in naturally Leishmania infantum-infected
dogs and related myelogram and hemogram changes. PLoS One.
2013;8(12), e82947.
9. De Oliveira CI, TM Gomes R, Barral A, Brodskyn C. Mortality due to visceral
leishmaniasis: clinical and laboratory characteristics. Drug Discov Today.
2004;1:81–6.
10. Moreno J, Alvar J. Canine leishmaniasis: epidemiological risk and the
experimental model. Trends Parasitol. 2002;18(9):399–405.
11. Barbosa Junior AA, Andrade ZA, Reed SG. The pathology of experimental
visceral leishmaniasis in resistant and susceptible lines of inbred mice. Braz J
Med Biol Res. 1987;20(1):63–72.
Moreira et al. Parasites & Vectors  (2016) 9:181 Page 11 of 13
12. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW. Th1
and Th2 cell-associated cytokines in experimental visceral leishmaniasis.
Infect Immun. 1994;62(3):1058–63.
13. Engwerda CR, Handwerger BS, Fox BS. Aged T cells are hyporesponsive to
costimulation mediated by CD28. J Immunol. 1994;152(8):3740–7.
14. Melby PC, Chandrasekar B, Zhao W, Coe JE. The hamster as a model of
human visceral leishmaniasis: progressive disease and impaired generation
of nitric oxide in the face of a prominent Th1-like cytokine response.
J Immunol. 2001;166(3):1912–20.
15. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, Gorak-Stolinska
PM, Kaye PM. A role for tumor necrosis factor-alpha in remodeling the
splenic marginal zone during Leishmania donovani infection. Am J Pathol.
2002;161(2):429–37.
16. Engwerda CR, Ato M, Kaye PM. Macrophages, pathology and parasite
persistence in experimental visceral leishmaniasis. Trends Parasitol.
2004;20(11):524–30.
17. Nieto CG, Vinuelas J, Blanco A, Garcia-Alonso M, Verdugo SG, Navarrete I.
Detection of Leishmania infantum amastigotes in canine choroid plexus. Vet
Rec. 1996;139(14):346–7.
18. Vinuelas J, Garcia-Alonso M, Ferrando L, Navarrete I, Molano I, Miron C, Carcelen J,
Alonso C, Nieto CG. Meningeal leishmaniosis induced by Leishmania infantum in
naturally infected dogs. Vet Parasitol. 2001;101(1):23–7.
19. Abreu-Silva AL, Calabrese KS, Tedesco RC, Mortara RA, Goncalves da Costa
SC. Central nervous system involvement in experimental infection with
Leishmania (Leishmania) amazonensis. Am J Trop Med Hyg. 2003;68(6):661–5.
20. Rolao N, Melo C, Campino L. Influence of the inoculation route in BALB/c
mice infected by Leishmania infantum. Acta Trop. 2004;90(1):123–6.
21. Carrion J, Nieto A, Iborra S, Iniesta V, Soto M, Folgueira C, Abanades DR,
Requena JM, Alonso C. Immunohistological features of visceral leishmaniasis
in BALB/c mice. Parasite Immunol. 2006;28(5):173–83.
22. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, de Oliveira CI,
Miranda JC, Elnaiem DE, Kamhawi S et al. Immunity to a salivary protein of a
sand fly vector protects against the fatal outcome of visceral leishmaniasis in a
hamster model. Proc Natl Acad Sci U S A. 2008;105(22):7845–50.
23. Nieto A, Dominguez-Bernal G, Orden JA, De La Fuente R, Madrid-Elena N,
Carrion J. Mechanisms of resistance and susceptibility to experimental
visceral leishmaniosis: BALB/c mouse versus Syrian hamster model. Vet Res.
2011;42:39.
24. Mookerjee A, Sen PC, Ghose AC. Immunosuppression in hamsters with
progressive visceral leishmaniasis is associated with an impairment of
protein kinase C activity in their lymphocytes that can be partially reversed
by okadaic acid or anti-transforming growth factor beta antibody. Infect
Immun. 2003;71(5):2439–46.
25. Goto H, Lindoso JA. Immunity and immunosuppression in experimental
visceral leishmaniasis. Braz J Med Biol Res. 2004;37(4):615–23.
26. Osorio EY, Zhao W, Espitia C, Saldarriaga O, Hawel L, Byus CV, Travi BL,
Melby PC. Progressive visceral leishmaniasis is driven by dominant parasite-
induced STAT6 activation and STAT6-dependent host arginase 1 expression.
PLoS Pathog. 2012;8(1), e1002417.
27. Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL.
Intracellular replication-deficient Leishmania donovani induces long lasting
protective immunity against visceral leishmaniasis. J Immunol.
2009;183(3):1813–20.
28. Samant M, Gupta R, Kumari S, Misra P, Khare P, Kushawaha PK, Travi BL,
Melby PC. Immunization with the DNA-encoding N-terminal domain of
proteophosphoglycan of Leishmania donovani generates Th1-type
immunoprotective response against experimental visceral leishmaniasis.
J Immunol. 2009;183(1):470–9.
29. Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B,
Naskar K, Haldar AK et al. Designing therapies against experimental visceral
leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.
Infect Immun. 2009;77(6):2330–42.
30. Kushawaha PK, Gupta R, Sundar S, Sahasrabuddhe AA, Dube A. Elongation
factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong
IFN-gamma and IL-12 response in cured Leishmania-infected patients/
hamsters and protects hamsters against Leishmania challenge. J Immunol.
2011;187(12):6417–27.
31. Prajapati VK, Awasthi K, Gautam S, Yadav TP, Rai M, Srivastava ON, Sundar S.
Targeted killing of Leishmania donovani in vivo and in vitro with
amphotericin B attached to functionalized carbon nanotubes. J Antimicrob
Chemother. 2011;66(4):874–9.
32. Selvapandiyan A, Dey R, Gannavaram S, Lakhal-Naouar I, Duncan R, Salotra
P, Nakhasi HL. Immunity to visceral leishmaniasis using genetically defined
live-attenuated parasites. J Trop Med. 2012;2012:631460.
33. Anuradha, Pal R, Katiyar JC. Sex-influenced population kinetics of Leishmania
donovani in hamsters. Indian J Exp Biol. 1990;28(9):876–9.
34. Singh N, Samant M, Gupta SK, Kumar A, Dube A. Age-influenced population
kinetics and immunological responses of Leishmania donovani in hamsters.
Parasitol Res. 2007;101(4):919–24.
35. Travi BL, Osorio Y, Melby PC, Chandrasekar B, Arteaga L, Saravia NG. Gender
is a major determinant of the clinical evolution and immune response in
hamsters infected with Leishmania spp. Infect Immun. 2002;70(5):2288–96.
36. Evans TG, Smith D, Pearson RD. Humoral factors and nonspecific immune
suppression in Syrian hamsters infected with Leishmania donovani.
J Parasitol. 1990;76(2):212–7.
37. Requena JM, Soto M, Doria MD, Alonso C. Immune and clinical parameters
associated with Leishmania infantum infection in the golden hamster
model. Vet Immunol Immunopathol. 2000;76(3–4):269–81.
38. Rica-Capela MJ, Cortes S, Leandro C, Peleteiro MC, Santos-Gomes G,
Campino L. Immunological and histopathological studies in a rodent model
infected with Leishmania infantum promastigotes or amastigotes. Parasitol
Res. 2003;89(3):163–9.
39. Dea-Ayuela MA, Rama-Iniguez S, Alunda JM, Bolas-Fernandez F. Setting new
immunobiological parameters in the hamster model of visceral
leishmaniasis for in vivo testing of antileishmanial compounds. Vet Res
Commun. 2007;31(6):703–17.
40. Wilson ME, Innes DJ, Sousa AD, Pearson RD. Early histopathology of
experimental infection with Leishmania donovani in hamsters. J Parasitol.
1987;73(1):55–63.
41. Melo F, Amaral M, Oliveira P, Lima W, Andrade M, Michalick M, Raso P, Tafuri
W, Tafuri W. Diffuse intralobular liver fibrosis in dogs naturally infected with
Leishmania (Leishmania) chagasi. Am J Trop Med Hyg. 2008;79(2):198–204.
42. Aslan H, Dey R, Meneses C, Castrovinci P, Jeronimo SM, Oliva G, Fischer L,
Duncan RC, Nakhasi HL, Valenzuela JG et al. A new model of progressive
visceral leishmaniasis in hamsters by natural transmission via bites of vector
sand flies. J Infect Dis. 2013;207(8):1328–38.
43. Vianna VL, Takiya CM, de Brito-Gitirana L. Histopathologic analysis of
hamster hepatocytes submitted to experimental infection with Leishmania
donovani. Parasitol Res. 2002;88(9):829–36.
44. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Carvalho MG, Mayrink W,
Franca-Silva JC, Giunchetti RC, Genaro O, Correa-Oliveira R. Parasite density
and impaired biochemical/hematological status are associated with severe
clinical aspects of canine visceral leishmaniasis. Res Vet Sci. 2006;81(1):68–75.
45. da Costa-Val AP, Cavalcanti RR, de Figueiredo GN, Michalick MS,
Alexander B, Williams P, Melo MN. Canine visceral leishmaniasis:
relationships between clinical status, humoral immune response,
haematology and Lutzomyia (Lutzomyia) longipalpis infectivity. Vet J.
2007;174(3):636–43.
46. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM,
Mayrink W, Tafuri WL, Correa-Oliveira R. Systemic and compartmentalized
immune response in canine visceral leishmaniasis. Vet Immunol Immunopathol.
2009;128(1–3):87–95.
47. Oliveira JMF, Fernandes AC, Dorval MEC, Alves TP, Fernandes TD, Oshiro ET,
Oliveira ALL. Mortality due to visceral leishmaniasis: clinical and laboratory
characteristics. Rev Soc Bras Med Trop. 2010;43(2):188-93.
48. Caldas AJ, Costa J, Aquino D, Silva AA, Barral-Netto M, Barral A. Are there
differences in clinical and laboratory parameters between children and
adults with American visceral leishmaniasis? Acta Trop. 2006;97(3):252–8.
49. Fernandez-Guerrero ML, Robles P, Rivas P, Mojer F, Muniz G, de Gorgolas M.
Visceral leishmaniasis in immunocompromised patients with and without
AIDS: a comparison of clinical features and prognosis. Acta Trop.
2004;90(1):11–6.
50. Moreno J, Nieto J, Masina S, Canavate C, Cruz I, Chicharro C, arrillo E, Napp
S, Reymond C, Kaye PM et al. Immunization with H1, HASPB1 and MML
Leishmania proteins in a vaccine trial against experimental canine
leishmaniasis. Vaccine. 2007;25(29):5290–300.
51. Campos Jr D. Clinical and epidemiological features of Kala-Azar in children.
Pediatr (Rio J). 1995;71:261–5.
52. Pearson RD, Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis.
1996;22(1):1–13.
53. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic
developments in the last 10 years. Clin Infect Dis. 1997;24(4):684–703.
Moreira et al. Parasites & Vectors  (2016) 9:181 Page 12 of 13
54. Nieto CG, Navarrete I, Habela MA, Serrano F, Redondo E. Pathological
changes in kidneys of dogs with natural Leishmania infection. Vet Parasitol.
1992;45(1–2):33–47.
55. Solano-Gallego L, Koutinas A, Miro G, Cardoso L, Pennisi MG, Ferrer L,
Bourdeau P, Oliva G, Baneth G. Directions for the diagnosis, clinical staging,
treatment and prevention of canine leishmaniosis. Vet Parasitol.
2009;165(1–2):1–18.
56. Solano-Gallego L, Miro G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L,
Bourdeau P, Oliva G, Baneth G, The LeishVet G. LeishVet guidelines for the
practical management of canine leishmaniosis. Parasit Vectors. 2011;4:86.
57. Zatelli A, Borgarelli M, Santilli R, Bonfanti U, Nigrisoli E, Zanatta R, Tarducci A,
Guarraci A. Glomerular lesions in dogs infected with Leishmania organisms.
Am J Vet Res. 2003;64(5):558–61.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Moreira et al. Parasites & Vectors  (2016) 9:181 Page 13 of 13
